Renu Virmani

Renu Virmani

President and Medical Director


CVPath Institute, Gaithersburg, MD, US

  • LinkedIn
  • OrcidID


Personal History

Dr Renu Virmani was born in 1943 in Pakistan. Her father was an industrialist of Delhi and Amritsar, India.2

As the youngest girl in a family of ten children, Dr Virmani was always driven to stand out and excel. Her aunt, who was a neurologist, was instrumental in forging her ambitions to pursue medicine. “I admired her and she showed me that women can do whatever they want,” she says.10

After meeting Professor Sylvan Weinburg, an influential cardiologist and president of the American College of Cardiology, she was introduced to Dr William (Bill) Roberts, who was known as ‘the man’ of cardiac pathology at the time.10 With Dr Roberts as her mentor, she began her journey towards qualifying as a cardiac pathologist. 

Virmani and her husband have a shared love of travel and support each other in their dedication to their demanding careers.2 They have two children and three grandchildren.8 Her favourite travel destinations are European cities and Manhattan.9


Academic History

Dr Virmani received her M.D. from Lady Hardinge Medical College, Delhi University, in New Delhi, India.1

She completed residencies in Gynecology, Obstetrics and Internal Medicine at Maulana Azad Medical College, New Delhi. Her Fellowships in Pathology were at the National Heart, Lung and Blood Institute in Bethesda, the Lala Lajpat Rai Memorial College and Hospital in Meerut and the George Washington University Medical Center in Washington, D.C.


Career Overview

After her fellowships, Dr Virmani returned to the National Heart, Lung and Blood Institute as a staff fellow until being hired as a staff pathologist at the Armed Forces Institute of Pathology (AFIP).2 She then left for Vanderbilt to work as Director of the Autopsy Service, but returned to AFIP in 1984 when she was offered the position of Chair of the Department of Cardiovascular Pathology.2 She also served in the reserves until 1989, based at Walter Reed Army Medical Center.2

Currently, Dr Virmani serves as the President of CVPath Institute, which she founded in 2005.7 It is an independent non-profit organization in Gaithersburg, MD dedicated to the study of cardiovascular diseases.

She is a Clinical Professor at the Department of Pathology at Georgetown University, University of Maryland-Baltimore, George Washington University and Vanderbilt University.10

Dr Virmani lectures at scientific meetings, both nationally and internationally and has delivered more than 800 presentations globally. She is a member of the American Heart Association, the U.S. and Canadian Academy of Pathology and is a Fellow of the American College of Cardiology. 

She is responsible for multiple research grants in the field of cardiovascular pathology and has authored or co-authored over 850 publications in peer-reviewed journals in the field of atherosclerosis, vulnerable plaque, stents and other cardiovascular diseases. She has edited 7 books and contributed over 100 book chapters.5 She regularly reviews manuscripts for a number of major scientific journals.

Dr Virmani also works as a consultant to Abbott Vascular, 480/Medical Arsenal Medical, Atrium Medical Corporation, Biosensors International, GlaxoSmithKline, CBard/Lutonix, Medtronic AVE, Terumo and W.L. Gore. 


Career Timeline

  • 1979 - 1981: Chief, Division of Cardiovascular Research, Armed Forces Institute of Pathology, Washington, D.C. 
  • 1984 - 2004: Chair, Department of Cardiovascular Pathology of the Armed Forces Institute of Pathology
  • 1988 - 1992: Member Cardiology Advisory Committee, national Heart, Lung and Blood Institute, National Institute of Health, Bethesda
  • 1989 - 1993: Member AIDS Advisory Committee, National Heart, Lung and Blood Institute, National Institutes of Health
  • 2005 - Present: President and Medical Director, CVPath Institute


Recognition1, 6, 10

  • Joint Service Commendation Medal for Outstanding Meritorious Service as Chief, Division of Cardiovascular Research, Armed Forces Institute of Pathology
  • 1981: Gold Medal for Best Scientific Exhibit at the American Society of Clinical Pathologists, Las Vegas, Nevada
  • 1985: Silver Medal for Second Best Scientific Exhibit at the American Society of Clinical Pathologists, Las Vegas, Nevada
  • 1988: Edward Rhodes Stitt Lecture Award, Association of Military Surgeons of the United States, San Antonio, Texas
  • 2006: Honorary degree fromEuroPCR
  • 2007: Society for Cardiovascular Pathology Distinguished Achievement Award
  • 2008: Honorary degree from the University of Antwerp, Belgium
  • 2008: Honorary degree from European Society of Cardiology 
  • 2010: Delivered the Laennec Clinician Educator Lecture
  • 2011: BAS Hugh Sinclair Lecture, British Atherosclerosis Society
  • 2012: TCT Career Achievement Award
  • 2012: Simon Dack Award from JACC Journals
  • 2012: RT Hall Lecture Award from International Faculty for CSANZ 2012 Brisbane
  • 2013: ICI 2013 Award (Innovations in Cardiovascular Interventions Award), Tel Aviv, Israel
  • 2014: Houston Methodist Leading Medicine Award from Houston Methodist Research Institute
  • 2014: Beacon of Interventional Cardiology Award from India Live 2015
  • Recognized by the Council on Clinical Cardiology of the American Heart Associations
  • 2015: TCT Career Achievement Award


Areas of Speciality5

  • Cardiovascular pathology
  • Atherosclerosis
  • Sudden coronary death





Dr Virmani is on the editorial board for Interventional Cardiology: Reviews, Research, Resources.

Articles by Renu Virmani, President and Medical Director

Vulnerable Plaque in Patients with Acute Coronary Syndrome: Identification, Importance, and Management

Atsushi Sakamoto, Anne Cornelissen, Yu Sato, et al


Citation: US Cardiology Review 2022;16:e01.

Dr Renu Virmani

Renu Virmani,

Citation: European Cardiology Review 2018;13(2):134–135.


Renu Virmani,

Citation: Interventional Cardiology 2011;6(2):104

A Selection of Significant Papers from the Past Year as Recommended by the European Cardiolovascular Disease 2006 Advisory Panel

Hans-Peter Brunner-La Rocca, Renu Virmani,

Citation: European Cardiovascular Disease 2006;2(1):14

HORIZONS and Drug-eluting Stent Usage in Acute Myocardial Infarction

Gaku Nakazawa, Masataka Nakano, Marc Vorpahl, et al

Citation: Interventional Cardiology 2009;4(1):53-6

Pathology of First-generation Drug-eluting Stents in Humans

Fumiyuki Otsuka, Masataka Nakano, Saami K Yazdani, et al

Citation: Interventional Cardiology 2011;6(1):28–35

Pathology of First-generation Drug-eluting Stents in Humans

Fumiyuki Otsuka, Masataka Nakano, Saami K Yazdani, et al

Citation: Asia-Pacific Cardiology 2011;3(1):52-9

Pre-clinical and Clinical Study Results for the Coracto™ Rapamycin-eluting Stent – A New-generation Drug-eluting Stent

Nicolaus Reifart, Mariann Gyöngyösi, Karl-Eugen Hauptmann, et al

Citation: Interventional Cardiology 2010;5:39–42

Morphologic Predictors of Drug-eluting Stent Thrombosis

Gaku Nakazawa, Aloke V Finn, Renu Virmani, et al

Citation: US Cardiology 2007;4(1):75–6